BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230123
DTEND;VALUE=DATE:20230125
DTSTAMP:20260516T051021
CREATED:20221007T091733Z
LAST-MODIFIED:20221007T091733Z
UID:35438-1674432000-1674604799@www.pharmajournalist.com
SUMMARY:Transdermal and Microneedle Drug Delivery
DESCRIPTION:SAE Media Group’s 2nd Annual Conference \nTransdermal and Microneedle Drug Delivery \nJanuary 23 – 24\, 2023 | London\, UK \nwww.transdermal-microneedle-delivery.co.uk/pharmajournalistel \n————————————————————————- \nSAE Media Group is proud to present the 2nd annual Transdermal and Microneedle Drug Delivery Conference\, taking place on the 23rd to 24th January 2023. \n \nThe 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed\, in combination with clinical trial optimization. Engage in the latest innovations in device design\, development and formulation\, with case studies from expert key opinion leaders of this rapidly accelerating space. Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease. \nThe two-day agenda offers you peer-to-peer networking with CEO’s\, Senior Vice presidents\, Directors\, Heads of Product Development and many more. \nBENEFITS OF ATTENDING: \n\nEngage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation\nGain insights from notified body and competent authority representatives addressing key regulatory requirements\nUnderstand how to optimize your lifecycle management strategy for a commercially successful device\nExplore and benchmark against industry advances in device design through case studies and real-world examples\n\nWHO SHOULD ATTEND: \n\nDrug-Delivery Device Developers\nMicroneedle Device Developers\nTransdermal Delivery Developers\nMicroarray Patch Developers\nMedical Device Engineers\nPrimary Packaging Material Designers\nSecondary Packagers\nSmart Device Developers\nTraining Device Developers\nDevice-Safety Solution Providers\nDrug Developers\nTransdermal Drug Product Developers\n\nEARLY-BIRD RATES:  \n\nBOOK BY 30TH SEPTEMBER AND SAVE £400\n\nRegistrations can be made on the event website at: www.transdermal-microneedle-delivery.co.uk/ \nTargeted Keywords \nTransdermal and Microneedle Drug Delivery\, transdermal\, drug development\, regulatory guidelines\, pharmaceutical industry\, drug delivery\, therapeutic sectors\, vaccines\, Parenteral administration\, combination products\, primary packaging\, sterile injectables\, connectivity\, human factors\, autoinjectors
URL:https://www.pharmajournalist.com/event/transdermal-and-microneedle-drug-delivery/
LOCATION:London\, UK
ORGANIZER;CN="SAE Media Group":MAILTO:RJones@smi-online.co.uk
END:VEVENT
END:VCALENDAR